VAN OORT DOUGLAS M 4
4 · NEOGENOMICS INC · Filed Mar 3, 2021
Insider Transaction Report
Form 4
VAN OORT DOUGLAS M
DirectorChairman and CEO
Transactions
- Tax Payment
Common Stock
2021-03-02−2,158→ 2,418,293 total - Award
Common Stock
2021-03-02+56,423→ 2,474,716 total - Tax Payment
Common Stock
2021-03-01−2,339→ 2,420,451 total
Holdings
- 231,567
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (231,567 underlying) - 225,084
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (225,084 underlying) - 500,000
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (500,000 underlying) - 15,000(indirect: By Children)
Common Stock
Footnotes (5)
- [F1]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
- [F2]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
- [F3]On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.